David D. Halbert

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ J. Russel Denton, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David D. Halbert

Form 4 holding Founder, Chairman, and Chief Executive Officer, Director, 10%+ Owner

Caris Life Sciences, Inc.

Security class
Common Stock
Shares / value
121,025,002
Estimated value
$2,163,927,035
Report date
15 May 2026
Price
$17.88
Ownership
Indirect
Form 4 holding Founder, Chairman, and Chief Executive Officer, Director, 10%+ Owner

Caris Life Sciences, Inc.

Security class
Common Stock
Shares / value
2,574,533
Estimated value
$46,032,650
Report date
15 May 2026
Price
$17.88
Ownership
Direct
Form 4 holding Founder, Chairman, and Chief Executive Officer, Director, 10%+ Owner

Caris Life Sciences, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
20 Jun 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Founder, Chairman, and Chief Executive Officer, Director, 10%+ Owner

Caris Life Sciences, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
20 Jun 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David D. Halbert

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .